Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Drug Delivery: Enteral Route01:18

Drug Delivery: Enteral Route

The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
Drugs in...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Constructing the Resilience-Induced Guise: A Grounded Theory Study of Opioid Use Experiences Among Black Women.

Substance use & misuse·2026
Same author

Female chronic pelvic pain: From trauma-informed assessment to evidence-based treatment.

JAAPA : official journal of the American Academy of Physician Assistants·2026
Same author

Alzheimer's disease-linked ACE variants increase ACE1 catalytic activity and production of angiotensin II.

The Journal of biological chemistry·2026
Same author

After Mandates End: Complex Decision Making Regarding COVID-19 Masking in San Diego Elementary Schools Through the Social Ecological Model.

The Journal of school health·2025
Same author

Observed Mask Wearing and Presence of SARS-CoV-2 in School Wastewater, San Diego County, CA, 2022.

American journal of public health·2025
Same author

Characteristics and career effect on PA graduates of a doctor of medical science program.

JAAPA : official journal of the American Academy of Physician Assistants·2024
Same journal

The evolution of the PA profession in Switzerland.

JAAPA : official journal of the American Academy of Physician Assistants·2026
Same journal

Use of dermoscopy and its association with skin lesion evaluation confidence among PAs in the United States.

JAAPA : official journal of the American Academy of Physician Assistants·2026
Same journal

Diabetic myonecrosis.

JAAPA : official journal of the American Academy of Physician Assistants·2026
Same journal

Acute coronary syndrome during active infusion of andexanet alfa.

JAAPA : official journal of the American Academy of Physician Assistants·2026
Same journal

Empowering PAs in health care: Unlocking the potential of implementation science.

JAAPA : official journal of the American Academy of Physician Assistants·2026
Same journal

The surgeon's tale.

JAAPA : official journal of the American Academy of Physician Assistants·2026
See all related articles

Related Experiment Video

Updated: May 12, 2026

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

Nitroglycerin use in STEMI locations.

Brenna Heaney1, Kaitlyn Zalar, Marlene Flores

  • 1Brenna Heaney, Kaitlyn Zalar, Marlene Flores, and Sarah Jessee are students at Emory and Henry College in Marion, VA. Elyse Watkins is an associate professor and associate DMSc program director at Northeastern University in Boston, MA. E. Watkins serves as a JAAPA clinical editor. The authors have disclosed no other potential conflicts of interest, financial or otherwise.

JAAPA : Official Journal of the American Academy of Physician Assistants
|March 24, 2026
PubMed
Summary
This summary is machine-generated.

Current guidelines advise against nitroglycerin for inferior ST-elevation myocardial infarction (STEMI). However, research indicates similar hypotension risks in inferior and non-inferior STEMI, suggesting protocol amendment for improved patient outcomes.

Keywords:
ACS protocolsSTEMIculprit lesionhypotensionmyocardial infarctionnitroglycerin

More Related Videos

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
07:59

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Published on: April 4, 2022

Echocardiography-guided Injection for Targeted and Reliable Intramyocardial Stem Cell Delivery in a Rat Model of Myocardial Infarction
06:47

Echocardiography-guided Injection for Targeted and Reliable Intramyocardial Stem Cell Delivery in a Rat Model of Myocardial Infarction

Published on: July 25, 2025

Related Experiment Videos

Last Updated: May 12, 2026

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
07:59

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Published on: April 4, 2022

Echocardiography-guided Injection for Targeted and Reliable Intramyocardial Stem Cell Delivery in a Rat Model of Myocardial Infarction
06:47

Echocardiography-guided Injection for Targeted and Reliable Intramyocardial Stem Cell Delivery in a Rat Model of Myocardial Infarction

Published on: July 25, 2025

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Clinical Research

Background:

  • Current acute coronary syndrome (ACS) protocols contraindicate nitroglycerin in inferior ST-elevation myocardial infarction (STEMI).
  • This is due to concerns that nitroglycerin's preload-reducing effects could cause detrimental hypotension in these patients.
  • Existing research suggests nitroglycerin-induced hypotension occurs at similar rates across different STEMI locations.

Purpose of the Study:

  • To evaluate the necessity of current contraindications for nitroglycerin in inferior STEMI.
  • To determine if nitroglycerin administration could benefit patients with inferior STEMI.
  • To advocate for protocol amendments based on evidence regarding nitroglycerin's safety and efficacy.

Main Methods:

  • Review of existing research and clinical data on nitroglycerin use in STEMI patients.
  • Comparative analysis of hypotension rates in inferior STEMI versus non-inferior STEMI.
  • Assessment of nitroglycerin's impact on myocardial function and patient outcomes.

Main Results:

  • Nitroglycerin-induced hypotension rates are comparable between inferior and non-inferior STEMI.
  • Hypotension development is linked to individual patient factors, not solely the infarct location.
  • Nitroglycerin may offer benefits in preserving myocardial function.

Conclusions:

  • Current ACS protocols regarding nitroglycerin for inferior STEMI require amendment.
  • Removing the contraindication could improve therapeutic options and patient survival.
  • Evidence supports reconsidering nitroglycerin's role in managing inferior STEMI.